News
Pete Pharma announced today a groundbreaking partnership with FABRX, the global pioneer of pharmaceutical 3D printing, to introduce this innovative technology to the U.S. compounding pharmacy market.
In this interview, Charles Chase, PhD, the VP and Technical Business Development at Asymchem, a technology-focused pharmaceutical manufacturing company, discusses the significant impact of RNA ...
Rapid scientific advances are accelerating the development of medical innovations, from personalized treatments to curative gene therapies and advanced diagnostic tools. But significant policy and ...
SYDNEY--(BUSINESS WIRE)--Novotech, a globally recognized full-service clinical research organization (CRO) and scientific advisory partner for biotech and small- to mid-sized pharmaceutical companies, ...
5d
Stockhead on MSNBig Pharma to showcase Clever Culture’s APAS Independence technology
AstraZeneca, Bristol Myers Squibb and Pfizer will present new evaluation performance data for Clever Culture Systems’ (ASX:CC5) Automated Plate Assessment System (APAS Independence). APAS uses ...
MINNEAPOLIS--(BUSINESS WIRE)--The National Institute for Pharmaceutical Technology and Education, Inc. (NIPTE) is pleased to announce the appointment of Ajaz Hussain, Ph.D., as its new executive ...
We can do 3d printing of medications in pill form… we’re looking at these ways how we can jump ahead of the curve using ...
It also touches upon the use of licensing in technology transfer and reviews the background to licensing. The report also analyzes the strategic options available to the biopharmaceutical and ...
Cambridge Advanced Research and Education in Singapore (CARES), the University of Cambridge's first overseas research centre, together with the A*STAR Institute for Infocomm Research (A*STAR I2R) has ...
Morocco’s pharmaceutical sector will undergo a major change as the country prepares for the introduction of a new drug ...
NEW YORK & BARRANQUILLA, Colombia--(BUSINESS WIRE)--Union Acquisition Corp. II (NASDAQ: LATN) (“LATN”), a special purpose acquisition company founded by Kyle P. Bransfield, today announced execution ...
India is planning to diversify its pharmaceutical export markets due to tariff uncertainties with the U.S. The country is ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results